<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  <title>PromptGenix – SBIR Overview</title>
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <meta name="description" content="PromptGenix SBIR Phase I overview: problem, innovation, aims, and feasibility for an evidence-weighted hypothesis intelligence engine."/>
  <style>
    *{ box-sizing:border-box; }
    body{
      margin:0;
      font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",sans-serif;
      background:#020617;
      color:#e5e7eb;
      line-height:1.5;
    }
    a{ color:inherit; text-decoration:none; }
    .page{ min-height:100vh; display:flex; flex-direction:column; }

    header{
      position:sticky; top:0; z-index:30;
      backdrop-filter: blur(14px);
      background: rgba(15, 23, 42, 0.92);
      border-bottom: 1px solid rgba(148, 163, 184, 0.3);
    }
    .nav{
      max-width:1120px; margin:0 auto; padding:14px 20px;
      display:flex; align-items:center; justify-content:space-between; gap:18px; flex-wrap:wrap;
    }
    .nav-left{ display:flex; align-items:center; gap:12px; }
    .logo-dot{
      width:28px; height:28px; border-radius:999px;
      background: radial-gradient(circle at 0 0,#38bdf8,#8b5cf6);
      box-shadow:0 0 18px rgba(56,189,248,.7);
    }
    .brand{ font-size:1.1rem; font-weight:650; letter-spacing:.04em; }
    .subbrand{ font-size:.72rem; color:#9ca3af; margin-top:2px; }

    .nav-links{ display:flex; gap:10px; flex-wrap:wrap; justify-content:flex-end; }
    .nav-links a{
      font-size:.88rem; color:#9ca3af;
      padding:6px 10px; border-radius:999px;
      border:1px solid rgba(148,163,184,0.18);
      background: rgba(2,6,23,0.25);
    }
    .nav-links a:hover{
      color:#e5e7eb;
      background: rgba(148,163,184,0.18);
      border-color: rgba(148,163,184,0.35);
    }
    .nav-links a.active{
      color:#e5e7eb;
      background: rgba(148,163,184,0.18);
      border-color: rgba(148,163,184,0.55);
    }

    main{ flex:1; }
    .section{ max-width:1120px; margin:0 auto; padding:28px 20px; }

    .topline{
      display:flex; flex-wrap:wrap; gap:10px;
      align-items:flex-end; justify-content:space-between;
      padding-top:16px; margin-bottom:14px;
    }
    .doc-title{
      font-size:1.45rem; font-weight:820; color:#f9fafb; margin:0;
    }
    .meta{ font-size:.78rem; color:#9ca3af; }

    .kicker{
      font-size:.78rem;
      text-transform:uppercase;
      letter-spacing:.18em;
      color:#a5b4fc;
      margin-bottom:6px;
    }
    h2{
      font-size:1.15rem;
      font-weight:760;
      color:#f9fafb;
      margin:14px 0 8px;
    }
    p{
      margin:0 0 10px;
      font-size:.93rem;
      color:#d1d5db;
    }

    .grid-2{
      display:grid;
      grid-template-columns:minmax(0,1.05fr) minmax(0,1fr);
      gap:18px; align-items:start;
      margin-top:10px;
    }
    .card{
      border-radius:16px;
      padding:14px 16px;
      background: rgba(15,23,42,0.84);
      border:1px solid rgba(148,163,184,0.28);
      box-shadow:0 18px 45px rgba(15,23,42,0.55);
    }
    .card h3{
      margin:0 0 8px;
      font-size:.95rem;
      letter-spacing:.14em;
      text-transform:uppercase;
      color:#a5b4fc;
    }

    ul{
      margin:6px 0 0;
      padding-left:1.1rem;
      color:#d1d5db;
      font-size:.92rem;
    }
    li{ margin-bottom:6px; }
    li strong{ color:#e5e7eb; }

    .pill-row{ display:flex; flex-wrap:wrap; gap:8px; margin-top:10px; }
    .pill{
      font-size:.72rem;
      padding:5px 9px;
      border-radius:999px;
      border:1px solid rgba(129,140,248,0.45);
      background: rgba(2,6,23,0.25);
      color:#c7d2fe;
      white-space:nowrap;
    }

    .callout{
      border-radius:14px;
      padding:12px 14px;
      border:1px dashed rgba(148,163,184,0.5);
      background: rgba(15,23,42,0.75);
      font-size:.88rem;
      color:#e5e7eb;
      margin-top:12px;
    }
    .callout strong{ color:#22c55e; }

    footer{
      border-top:1px solid rgba(31,41,55,0.9);
      padding:16px;
      font-size:.78rem;
      color:#6b7280;
      text-align:center;
    }

    @media (max-width:920px){
      .grid-2{ grid-template-columns:minmax(0,1fr); }
    }

    @media print{
      header, footer{ display:none !important; }
      body{ background:#fff; color:#111; }
      p, li{ color:#111; }
      .kicker, .card h3{ color:#111; }
      .card, .callout{ background:#fff; box-shadow:none; }
      .section{ max-width:100%; padding:0; }
    }
  </style>
</head>

<body>
<div class="page">
  <header>
    <div class="nav">
      <div class="nav-left">
        <div class="logo-dot"></div>
        <div>
          <div class="brand">PromptGenix</div>
          <div class="subbrand">SBIR Portal</div>
        </div>
      </div>

      <nav class="nav-links">
        <a href="index.html">Portal</a>
        <a href="sbir.html" class="active">SBIR</a>
        <a href="aims.html">Aims</a>
        <a href="approach.html">Approach</a>
        <a href="commercialization.html">Commercialization</a>
        <a href="facilities.html">Facilities</a>
        <a href="team.html">Team</a>
        <a href="use-cases.html">Use Cases</a>
      </nav>
    </div>
  </header>

  <main>
    <section class="section">
      <div class="topline">
        <h1 class="doc-title">SBIR Phase I Overview</h1>
        <div class="meta">
          PromptGenix LLC · Women &amp; Minority-Owned · Contact: dohoon.kim1@icloud.com
        </div>
      </div>

      <div class="kicker">The problem</div>
      <h2>Biomedical data generation outpaces scientific decision-making.</h2>
      <p>
        NIH-funded programs generate large volumes of multi-modal biomedical data and publications, yet a core bottleneck remains:
        converting heterogeneous evidence into <strong>ranked hypotheses</strong>, <strong>clear uncertainty</strong>, and <strong>concrete next-step decisions</strong>.
        Teams often rely on fragmented tools, ad hoc scripts, and scarce expert time, leading to slow turnaround and inconsistent reproducibility.
      </p>

      <div class="kicker">The innovation</div>
      <h2>PromptGenix: an evidence-weighted hypothesis intelligence engine.</h2>
      <p>
        PromptGenix integrates public biomedical datasets and literature into a traceable decision workflow that produces
        <strong>testable hypotheses</strong> with <strong>confidence ranking</strong> and <strong>explicit evidence links</strong>.
        The system uses statistical and Bayesian methods to quantify uncertainty, while LLMs are constrained to
        explanation and synthesis under strict traceability guardrails.
      </p>

      <div class="grid-2">
        <div class="card">
          <h3>What is new (technical)</h3>
          <ul>
            <li><strong>Evidence objects:</strong> standardized representation of signals from public datasets and literature</li>
            <li><strong>Probabilistic ranking:</strong> statistical scoring + Bayesian updating to compute posterior confidence</li>
            <li><strong>Traceability:</strong> every hypothesis includes “why” and links to supporting/conflicting evidence</li>
            <li><strong>LLM guardrails:</strong> narrative generation is evidence-bound (“no evidence → no claim”)</li>
          </ul>
          <div class="pill-row">
            <span class="pill">Bayesian confidence</span>
            <span class="pill">Calibration</span>
            <span class="pill">Citations</span>
            <span class="pill">Audit-friendly</span>
          </div>
        </div>

        <div class="card">
          <h3>SBIR Phase I scope</h3>
          <ul>
            <li><strong>Build:</strong> validated prototype that generates ranked hypotheses and reviewer-ready reports</li>
            <li><strong>Validate:</strong> traceability, reproducibility across reruns, and usefulness for study decisions</li>
            <li><strong>Measure:</strong> time-to-hypothesis, rerun consistency, and pilot “useful” ratings</li>
            <li><strong>Deliver:</strong> HTML/PDF artifacts suitable for review and partner discussions</li>
          </ul>
          <div class="callout">
            <strong>Boundary:</strong> Phase I evaluation uses public datasets only (e.g., GEO, SRA, FlowRepository) to avoid IP/data-use constraints.
          </div>
        </div>
      </div>

      <div class="kicker" style="margin-top:18px;">Why it matters</div>
      <h2>Faster, more rigorous science—without requiring more expert bandwidth.</h2>
      <p>
        PromptGenix helps research teams move from “outputs” to “decisions” by producing ranked hypotheses with transparent uncertainty.
        This enables clearer experimental planning, more reproducible interpretation, and improved reviewer confidence in how conclusions were reached.
      </p>

      <div class="callout">
        <strong>Phase II path:</strong> Phase I de-risks the core decision engine; Phase II scales to broader modalities, multi-site usage,
        and secure deployments for real-world partner settings.
      </div>
    </section>
  </main>

  <footer>
    PromptGenix · SBIR Portal ·
    <a href="mailto:dohoon.kim1@icloud.com">dohoon.kim1@icloud.com</a>
  </footer>
</div>
</body>
</html>
